Through this transaction, which marks M&M's foray into global combine harvester business, two companies aim to take Sampo's combine harvesters to new markets globally, including India
The companies plan to create a tiered vendor base for supporting, indigenisation and localisation requirements and seeks to set up a final assembly line for unmanned aircraft systems
JV, which will set up manufacturing unit at Pithampur (MP) with an initial capital outlay of more than Rs 1,300 crore, will focus on air-to-air missiles, air defence systems and large aerostats
Built with a capacity to manufacture 15 MT per day in the first phase, the plant is expected to manufacture 1.2 million tyres when fully operational
The project includes new ethylene cracker and ethylene derivatives units, and a styrene monomer and propylene oxide (SMPO) plant
The acquisition of Hexion PAC significantly strengthens Synthomer's position in the global dispersions and additives market, particularly in the US and Asia
The company plans to expand masterbatches capacity at Givet site to meet the growing demand in France and other European countries
The company will begin construction of the new plant in June this year and aims to start operation from October 2017
Early this month, the company, which has been augmenting the manufacturing capacity of masterbatches, announced its plans to build a plant in West Bengal to tap the Eastern region
As per the deal, Honeywell will license its proprietary technologies to produce the refrigerant to Navin Fluorine, which will manufacture Solstice yf in India exclusively for Honeywell
The acquisition of off-highway tyre maker ATG will strengthen Yokohama Rubber's product line-up in commercial tyres
The acquisition is expected to strengthen Zydus Group's presence in gastroenterology segment
Cabapan has been developed by Panacea Biotec's global research and development center located at Mumbai
It will also receive contingent payments up to $ 18 million from its 10% interest as a limited partner in one of the venture funds specialised in investing in early stage drug discovery firms
As per the agreement, XenoPort will receive a $47.5 million up-front payment and an additional $2.5 million for transfer of certain clinical trial materials to Dr Reddy's Laboratories
The approved product, rivastigmine tartrate capsules, is generic version of Novartis' Exelon and has an estimated market size of $ 26.7 million
With this approval, Biocon aims to capture a significant share of the Japanese glargine market of $ 144 million, which is the second largest market outside of North America & Europe
Smith & Nephew intends to expand the Navio platform into total knee, bi-cruciate retaining knee and revision knee implants
With the acquisition of these brands, which have combined annualised revenues of approximately $ 160 million, Sun Pharma enters Japanese prescription market
The company has decided to the shutdown, started from March 22, 2016, for carrying out maintenance